PARSIPPANY, N.J. (AP) _ Pacira Pharmaceuticals Inc. (PCRX) on Thursday reported a loss of $2.8 million in its first quarter.
The Parsippany, New Jersey-based company said it had a loss of 7 cents per share. Earnings, adjusted for stock option expense and amortization costs, came to 22 cents per share.
The results did not meet Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 24 cents per share.
The specialty drugmaker posted revenue of $91.3 million in the period, exceeding Street forecasts. Seven analysts surveyed by Zacks expected $91.1 million.
Pacira shares have increased 7.5% since the beginning of the year. The stock has risen 36% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PCRX at https://www.zacks.com/ap/PCRX